Aktuellt
SENASTE
Redeye endorses Iconovo’s new order from a Top-10 pharma company to evaluate a multi-dose inhaler from Iconovo. The order value amounts to SEK220,000, which we argue is in the lower region. However, this order may lead to further collaboration; therefore, we look forward to the feedback from the customer.
LÄS MER
